Index S&P 500 P/E 16.79 EPS (ttm) 23.81 Insider Own 28.93% Shs Outstand 236.14M Perf Week -3.30%
Market Cap 93.54B Forward P/E 14.08 EPS next Y 28.38 Insider Trans -0.03% Shs Float 166.30M Perf Month 1.00%
Enterprise Value 142.02B PEG 1.29 EPS next Q 5.72 Inst Own 64.11% Short Float 2.57% Perf Quarter 8.45%
Income 5.97B P/S 1.29 EPS this Y 19.91% Inst Trans -5.07% Short Ratio 3.08 Perf Half Y 21.70%
Sales 72.70B P/B - EPS next Y 7.78% ROA 10.21% Short Interest 4.27M Perf YTD 33.18%
Book/sh -18.61 P/C 89.94 EPS next 5Y 13.02% ROE - 52W High 420.98 -5.04% Perf Year 2.06%
Cash/sh 4.44 P/FCF 12.83 EPS past 3/5Y 1.31% 16.93% ROIC 16.20% 52W Low 289.98 37.85% Perf 3Y 81.95%
Dividend Est. 2.86 (0.72%) EV/EBITDA 9.80 Sales past 3/5Y 6.32% 6.58% Gross Margin 15.24% Volatility 3.16% 2.37% Perf 5Y 198.74%
Dividend TTM 2.82 (0.71%) EV/Sales 1.95 EPS Y/Y TTM 11.25% Oper. Margin 15.24% ATR (14) 9.96 Perf 10Y 357.28%
Dividend Ex-Date Sep 16, 2025 Quick Ratio 0.86 Sales Y/Y TTM 6.37% Profit Margin 8.21% RSI (14) 50.80 Recom 2.11
Dividend Gr. 3/5Y 11.20% 10.53% Current Ratio 0.98 EPS Q/Q 23.51% SMA20 -1.61% Beta 1.40 Target Price 403.14
Payout 12.00% Debt/Eq - Sales Q/Q 6.36% SMA50 4.29% Rel Volume 0.95 Prev Close 403.17
Employees 316000 LT Debt/Eq - Earnings Jul 25 BMO SMA200 14.49% Avg Volume 1.39M Price 399.75
IPO Mar 10, 2011 Option/Short Yes / Yes EPS/Sales Surpr. 8.68% 0.57% Trades
Volume 1,319,769 Change -0.85%
Date
Action
Analyst
Rating Change
Price Target Change
Jul-28-25 Downgrade Wolfe Research
Outperform → Peer Perform
Jul-16-25 Downgrade BofA Securities
Buy → Neutral
$394
May-29-25 Upgrade Wells Fargo
Underweight → Equal Weight
$385
Apr-15-25 Downgrade Robert W. Baird
Outperform → Neutral
$336
Dec-17-24 Resumed JP Morgan
Neutral
$380
Nov-25-24 Downgrade Wells Fargo
Equal Weight → Underweight
$400 → $320
Nov-22-24 Downgrade Raymond James
Outperform → Mkt Perform
Oct-11-24 Initiated KeyBanc Capital Markets
Overweight
$475
Sep-03-24 Initiated Morgan Stanley
Equal-Weight
$427
May-30-24 Initiated Robert W. Baird
Outperform
$396
Mar-06-24 Initiated Barclays
Overweight
$356
Jan-04-24 Downgrade Bernstein
Outperform → Mkt Perform
$277 → $301
Dec-11-23 Downgrade Goldman
Buy → Neutral
$271
Apr-21-23 Initiated Cantor Fitzgerald
Overweight
$304
Apr-19-23 Resumed JP Morgan
Neutral
$257 → $283
Jul-06-22 Downgrade BMO Capital Markets
Market Perform → Underperform
$233 → $160
Jun-17-22 Initiated Loop Capital
Buy
$240
May-27-22 Upgrade Bernstein
Mkt Perform → Outperform
$273 → $271
Mar-29-22 Initiated Wells Fargo
Equal Weight
$267
Jan-10-22 Resumed Citigroup
Buy
$274 → $306
Show Previous Ratings
Sep-16-25 12:35PM
Sep-11-25 09:50AM
07:00AM
Sep-10-25 08:30AM
Sep-08-25 04:49PM
03:17AM
Loading…
Sep-05-25 03:17AM
Sep-03-25 09:45AM
Sep-02-25 12:33PM
Aug-29-25 09:40AM
Aug-27-25 04:30PM
Aug-25-25 09:30AM
Aug-22-25 08:32AM
Aug-19-25 10:09AM
Aug-18-25 09:45AM
Aug-14-25 09:30AM
08:30AM
Loading…
08:30AM
05:13AM
Aug-13-25 04:30PM
09:40AM
12:18AM
12:10AM
Aug-11-25 09:50AM
Aug-08-25 06:45PM
02:00PM
Aug-07-25 12:28PM
Aug-06-25 06:00AM
Aug-04-25 01:18PM
11:14AM
Aug-02-25 07:00AM
Jul-31-25 08:50AM
01:41PM
Loading…
Jul-30-25 01:41PM
02:27AM
Jul-29-25 01:42PM
Jul-28-25 02:01PM
05:00AM
Jul-26-25 03:07AM
Jul-25-25 02:50PM
01:43PM
01:11PM
10:10AM
09:06AM
(Investor's Business Daily)
08:40AM
08:24AM
(The Wall Street Journal)
08:12AM
07:51AM
(Associated Press Finance)
07:44AM
07:30AM
Jul-24-25 09:45AM
Jul-23-25 11:02PM
09:40AM
Jul-22-25 09:15AM
07:55AM
03:28AM
Jul-21-25 10:35AM
09:23AM
Jul-20-25 05:00AM
Jul-18-25 10:00AM
12:05AM
Jul-17-25 08:29AM
Jul-16-25 12:11PM
Jul-11-25 08:30AM
Jul-07-25 09:45AM
06:00AM
Jul-04-25 09:40AM
Jul-02-25 04:30PM
Jul-01-25 08:14AM
Jun-30-25 04:00PM
08:45AM
Jun-29-25 02:45PM
Jun-28-25 04:16AM
Jun-26-25 04:12PM
(Investor's Business Daily)
01:43PM
08:30AM
Jun-24-25 01:07PM
Jun-23-25 08:30AM
Jun-22-25 11:33PM
Jun-19-25 09:45AM
Jun-18-25 09:40AM
Jun-17-25 11:15AM
Jun-16-25 12:08PM
Jun-15-25 05:39AM
Jun-09-25 03:58PM
02:06PM
(The Wall Street Journal)
09:30AM
08:30AM
Jun-05-25 08:30AM
Jun-04-25 09:50AM
Jun-03-25 09:45AM
Jun-02-25 09:40AM
May-28-25 04:07PM
11:30AM
May-27-25 09:30AM
May-22-25 11:58PM
08:30AM
May-21-25 08:30AM
May-16-25 12:00PM
09:45AM
09:40AM
09:30AM
May-15-25 04:59PM
HCA Healthcare, Inc. is a health care services company engaged in operating hospitals, freestanding surgery centers and emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, comprehensive rehabilitation and physical therapy centers, physician practices, home health, hospice, outpatient physical therapy home and community-based services providers, and various other facilities. The firm operates general and acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services, and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company was founded by Dr. Thomas F. Frist, Jr in 1968 and is headquartered in Nashville, TN.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Cuffe Michael S. Officer Sep 08 '25 Proposed Sale 418.84 3,836 1,606,670 Sep 08 08:15 PM Cuffe Michael S. EVP and Chief Clinical Officer Sep 04 '25 Option Exercise 173.12 10,920 1,890,470 42,423 Sep 08 06:37 PM Cuffe Michael S. EVP and Chief Clinical Officer Sep 08 '25 Sale 418.84 3,836 1,606,670 31,503 Sep 08 06:37 PM Foster Jon M EVP and COO May 13 '25 Sale 369.32 15,698 5,797,661 12,646 May 15 05:54 PM Foster Jon M Officer May 13 '25 Proposed Sale 369.32 15,698 5,797,660 May 13 04:05 PM Berres Jennifer SVP & Chief Human Res. Officer Feb 14 '25 Sale 322.59 9,533 3,075,240 15,412 Feb 18 07:28 PM Berres Jennifer Officer Feb 14 '25 Proposed Sale 322.59 9,533 3,075,238 Feb 14 04:26 PM Berres Jennifer SVP & Chief Human Res. Officer Feb 07 '25 Option Exercise 115.12 11,780 1,356,151 30,511 Feb 11 06:16 PM Reiner Deborah M Former Officer Feb 11 '25 Proposed Sale 322.39 3,510 1,131,589 Feb 11 05:07 PM Whalen Kathleen M Former Officer Jan 31 '25 Proposed Sale 335.25 3,228 1,082,203 Jan 31 04:12 PM Whalen Kathleen M SVP & Chief Ethics Officer Nov 14 '24 Sale 357.99 1,474 527,677 9,454 Nov 18 05:50 PM Foster Jon M EVP and COO Nov 14 '24 Option Exercise 101.16 36,600 3,702,456 47,180 Nov 18 05:47 PM Billington Phillip G SVP-Internal Audit Services Nov 12 '24 Option Exercise 68.96 8,000 551,680 60,702 Nov 14 06:53 PM Billington Phillip G SVP-Internal Audit Services Nov 14 '24 Sale 350.00 3,897 1,363,950 52,702 Nov 14 06:53 PM Akdamar Erol R Group President Nov 12 '24 Option Exercise 68.96 20,000 1,379,200 20,000 Nov 14 06:50 PM Akdamar Erol R Group President Nov 14 '24 Sale 353.00 2,900 1,023,700 6,843 Nov 14 06:50 PM Whalen Kathleen M Officer Nov 14 '24 Proposed Sale 357.99 1,474 527,677 Nov 14 06:20 PM Akdamar Erol R Officer Nov 14 '24 Proposed Sale 357.86 4,872 1,743,480 Nov 14 06:19 PM Billington Phillip G Officer Nov 14 '24 Proposed Sale 350.00 3,897 1,363,950 Nov 14 06:17 PM Whalen Kathleen M SVP & Chief Ethics Officer Nov 11 '24 Option Exercise 173.12 4,710 815,395 14,164 Nov 13 06:17 PM
